242 related articles for article (PubMed ID: 22036785)
1. Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases.
Cleland SY; Siegel RM
FEBS Lett; 2011 Dec; 585(23):3710-4. PubMed ID: 22036785
[TBL] [Abstract][Full Text] [Related]
2. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
Du HQ; Zhang X; An YF; Ding Y; Zhao XD
Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
[TBL] [Abstract][Full Text] [Related]
3. WASP: a key immunological multitasker.
Thrasher AJ; Burns SO
Nat Rev Immunol; 2010 Mar; 10(3):182-92. PubMed ID: 20182458
[TBL] [Abstract][Full Text] [Related]
4. Wiskott-Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans.
Castiello MC; Bosticardo M; Pala F; Catucci M; Chamberlain N; van Zelm MC; Driessen GJ; Pac M; Bernatowska E; Scaramuzza S; Aiuti A; Sauer AV; Traggiai E; Meffre E; Villa A; van der Burg M
J Autoimmun; 2014 May; 50(100):42-50. PubMed ID: 24369837
[TBL] [Abstract][Full Text] [Related]
5. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome.
Adriani M; Aoki J; Horai R; Thornton AM; Konno A; Kirby M; Anderson SM; Siegel RM; Candotti F; Schwartzberg PL
Clin Immunol; 2007 Jul; 124(1):41-8. PubMed ID: 17512803
[TBL] [Abstract][Full Text] [Related]
6. The role of WASp in T cells and B cells.
Sun X; Wei Y; Lee PP; Ren B; Liu C
Cell Immunol; 2019 Jul; 341():103919. PubMed ID: 31047647
[TBL] [Abstract][Full Text] [Related]
7. Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
Prete F; Catucci M; Labrada M; Gobessi S; Castiello MC; Bonomi E; Aiuti A; Vermi W; Cancrini C; Metin A; Hambleton S; Bredius R; Notarangelo LD; van der Burg M; Kalinke U; Villa A; Benvenuti F
J Exp Med; 2013 Feb; 210(2):355-74. PubMed ID: 23337808
[TBL] [Abstract][Full Text] [Related]
8. Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein.
Nikolov NP; Shimizu M; Cleland S; Bailey D; Aoki J; Strom T; Schwartzberg PL; Candotti F; Siegel RM
Blood; 2010 Aug; 116(5):740-7. PubMed ID: 20457871
[TBL] [Abstract][Full Text] [Related]
9. Wiskott-Aldrich syndrome protein: Emerging mechanisms in immunity.
Rivers E; Thrasher AJ
Eur J Immunol; 2017 Nov; 47(11):1857-1866. PubMed ID: 28805251
[TBL] [Abstract][Full Text] [Related]
10. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
[TBL] [Abstract][Full Text] [Related]
11. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
Blundell MP; Worth A; Bouma G; Thrasher AJ
Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
[TBL] [Abstract][Full Text] [Related]
12. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome.
Taylor MD; Sadhukhan S; Kottangada P; Ramgopal A; Sarkar K; D'Silva S; Selvakumar A; Candotti F; Vyas YM
Sci Transl Med; 2010 Jun; 2(37):37ra44. PubMed ID: 20574068
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity in Wiskott-Aldrich syndrome.
Schurman SH; Candotti F
Curr Opin Rheumatol; 2003 Jul; 15(4):446-53. PubMed ID: 12819473
[TBL] [Abstract][Full Text] [Related]
14. Abnormal O-glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome.
Khan S; Holding S; Doré PC; Sewell WA
Med Hypotheses; 2008; 70(2):269-72. PubMed ID: 17664047
[TBL] [Abstract][Full Text] [Related]
15. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
[TBL] [Abstract][Full Text] [Related]
16. N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome.
Volpi S; Santori E; Abernethy K; Mizui M; Dahlberg CI; Recher M; Capuder K; Csizmadia E; Ryan D; Mathew D; Tsokos GC; Snapper S; Westerberg LS; Thrasher AJ; Candotti F; Notarangelo LD
Blood; 2016 Jan; 127(2):216-20. PubMed ID: 26468226
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral-mediated gene therapy restores B cell tolerance in Wiskott-Aldrich syndrome patients.
Pala F; Morbach H; Castiello MC; Schickel JN; Scaramuzza S; Chamberlain N; Cassani B; Glauzy S; Romberg N; Candotti F; Aiuti A; Bosticardo M; Villa A; Meffre E
J Clin Invest; 2015 Oct; 125(10):3941-51. PubMed ID: 26368308
[TBL] [Abstract][Full Text] [Related]
18. [Molecular pathogenesis of Wiskott-Aldrich syndrome].
Sasahara Y; Tsuchiya S
Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):140-7. PubMed ID: 15997177
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
Ochs HD
Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
[TBL] [Abstract][Full Text] [Related]
20. Wiskott-Aldrich Syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation.
Bouma G; Burns SO; Thrasher AJ
Immunobiology; 2009; 214(9-10):778-90. PubMed ID: 19628299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
